Nature Communications · 2019 · 79 citations · 50 references
MedicineCancer BiologyOncologyMolecular OncologyOncogenesProteomicsCancer ProteomicsCancer TranscriptomicsMolecular Tumor ProfilingOncogenic Signaling PathwaysProteomic ProfilingSignal Transduction In CancerCancer Proteome ProfilingCrispr-cas9 ValidationMap KinasesOncogenic TransformationPathway Activity ProfilingTumor ProfilingTumor Proteome ProfilingTumor Proteomics
High throughput omics approaches provide an unprecedented opportunity for dissecting molecular mechanisms in cancer biology. Here we present deep profiling of whole proteome, phosphoproteome and transcriptome in two high-grade glioma (HGG) mouse models driven by mutated RTK oncogenes, PDGFRA and NTRK1, analyzing 13,860 proteins and 30,431 phosphosites by mass spectrometry. Systems biology approaches identify numerous master regulators, including 41 kinases and 23 transcription factors. Pathway activity computation and mouse survival indicate the NTRK1 mutation induces a higher activation of AKT downstream targets including MYC and JUN, drives a positive feedback loop to up-regulate multiple other RTKs, and confers higher oncogenic potency than the PDGFRA mutation. A mini-gRNA library CRISPR-Cas9 validation screening shows 56% of tested master regulators are important for the viability of NTRK-driven HGG cells, including TFs (Myc and Jun) and metabolic kinases (AMPKa1 and AMPKa2), confirming the validity of the multiomics integrative approaches, and providing novel tumor vulnerabilities.
50
WGCNA: an R package for weighted correlation network analysis
Peter Langfelder, Steve Horvath · BMC Bioinformatics · 2008 · 29.1K citations · Full text
An integrated encyclopedia of DNA elements in the human genome
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Global quantification of mammalian gene expression control
Björn Schwanhäußer, Dorothea Busse, Na Li et al. · Nature · 2011 · 6.9K citations